Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Klever-Deichert

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Herz|February 1, 2002
[Cost effectiveness of lipid lowering therapy]G Wendland, G Klever-Deichert, K Lauterbach
Zeitschrift Fur Kardiologie|November 20, 2002
[Cost-effectiveness of coronary heart disease prevention]G Wendland, G Klever-Deichert, K Lauterbach
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|June 3, 2006
[Effects of tobacco tax increase on cigarette consumption and the impact on health policy]E Plamper, G Klever Deichert, K W Lauterbach
Medizinische Klinik (Munich, Germany : 1983)|August 10, 2000
[Cost-benefit analysis of an evidence-based secondary prevention of coronary heart diseases by statins. An analysis for Germany from a social security perspective]G Klever-Deichert, B Hinzpeter, G Wendland, et al.
Herz|September 19, 2000
[Coronary disease and social security. A simulation model on cost analysis]B Hinzpeter, G Klever-Deichert, G Wendland, et al.
Zeitschrift Fur Kardiologie|November 1, 2005
[Cost-effectiveness of prevention of coronary disease in Germany]K W Lauterbach, A Gerber, G Klever-Deichert, et al.
Zeitschrift Fur Kardiologie|February 2, 2000
[Costs of coronary heart diseases over the remaining life time in coronary heart disease cases--an analysis of the current status of coronary heart disease cases in Germany from the social perspective]G Klever-Deichert, B Hinzpeter, E Hunsche, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Herz|February 1, 2002
[Cost effectiveness of lipid lowering therapy]G Wendland, G Klever-Deichert, K Lauterbach
Zeitschrift Fur Kardiologie|November 20, 2002
[Cost-effectiveness of coronary heart disease prevention]G Wendland, G Klever-Deichert, K Lauterbach
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|June 3, 2006
[Effects of tobacco tax increase on cigarette consumption and the impact on health policy]E Plamper, G Klever Deichert, K W Lauterbach
Medizinische Klinik (Munich, Germany : 1983)|August 10, 2000
[Cost-benefit analysis of an evidence-based secondary prevention of coronary heart diseases by statins. An analysis for Germany from a social security perspective]G Klever-Deichert, B Hinzpeter, G Wendland, et al.
Herz|September 19, 2000
[Coronary disease and social security. A simulation model on cost analysis]B Hinzpeter, G Klever-Deichert, G Wendland, et al.
Zeitschrift Fur Kardiologie|November 1, 2005
[Cost-effectiveness of prevention of coronary disease in Germany]K W Lauterbach, A Gerber, G Klever-Deichert, et al.
Zeitschrift Fur Kardiologie|February 2, 2000
[Costs of coronary heart diseases over the remaining life time in coronary heart disease cases--an analysis of the current status of coronary heart disease cases in Germany from the social perspective]G Klever-Deichert, B Hinzpeter, E Hunsche, et al.
Pageof 1